Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Hellmann

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
Nature|July 22, 2021
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancersJustina X Caushi, Jiajia Zhang, Zhicheng Ji, et al.
Nature Medicine|June 29, 2021
Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a childMasato Ogishi, Rui Yang, Caner Aytekin, et al.
Nature|October 5, 2021
Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancersJustina X Caushi, Jiajia Zhang, Zhicheng Ji, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2022
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT RegistryJennifer G Whisenant, Javier Baena, Alessio Cortellini, et al.
Nature Genetics|January 16, 2019
Tumor mutational load predicts survival after immunotherapy across multiple cancer typesRobert M Samstein, Chung-Han Lee, Alexander N Shoushtari, et al.
Nature Medicine|November 10, 2022
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancerJustin Jee, Emily S Lebow, Randy Yeh, et al.
Cancer Discovery|May 19, 2018
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung AdenocarcinomaFerdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, et al.
Nature Medicine|May 9, 2017
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patientsAhmet Zehir, Ryma Benayed, Ronak H Shah, et al.
Nature Medicine|August 5, 2017
Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patientsAhmet Zehir, Ryma Benayed, Ronak H Shah, et al.
Nature Communications|May 13, 2020
Protein-altering germline mutations implicate novel genes related to lung cancer developmentXuemei Ji, Semanti Mukherjee, Maria Teresa Landi, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Nature|July 22, 2021
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancersJustina X Caushi, Jiajia Zhang, Zhicheng Ji, et al.
Nature Medicine|June 29, 2021
Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a childMasato Ogishi, Rui Yang, Caner Aytekin, et al.
Nature|October 5, 2021
Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancersJustina X Caushi, Jiajia Zhang, Zhicheng Ji, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2022
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT RegistryJennifer G Whisenant, Javier Baena, Alessio Cortellini, et al.
Nature Genetics|January 16, 2019
Tumor mutational load predicts survival after immunotherapy across multiple cancer typesRobert M Samstein, Chung-Han Lee, Alexander N Shoushtari, et al.
Nature Medicine|November 10, 2022
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancerJustin Jee, Emily S Lebow, Randy Yeh, et al.
Cancer Discovery|May 19, 2018
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung AdenocarcinomaFerdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, et al.
Nature Medicine|May 9, 2017
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patientsAhmet Zehir, Ryma Benayed, Ronak H Shah, et al.
Nature Medicine|August 5, 2017
Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patientsAhmet Zehir, Ryma Benayed, Ronak H Shah, et al.
Nature Communications|May 13, 2020
Protein-altering germline mutations implicate novel genes related to lung cancer developmentXuemei Ji, Semanti Mukherjee, Maria Teresa Landi, et al.
Pageof 18